Novartis’s Afinitor shows promise in breast cancer (Reuters)
Reuters – C ombining two drugs from Novartis and Pfizer to treat post-menopausal women with a certain type of advanced breast cancer more than doubled the time they lived without their disease getting worse, study data showed on Monday.
View full post on Yahoo! News: Health News
Leave a Reply